These tumors were MLH1 deficient and were characterized by the well-known clinical-pathological features associated with MSI, such as older age onset, right tumor site, specific histological types (mucinous or medullary/undifferentiated tumors), high histological grade, and high content of CD8+ TILs. This evidence concerns the gene CD8A and neoplasm.